The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback